top of page
Image 5.png

Life Sciences Commercialization

We operate as your North America commercial launch operator, from coverage to adoption.

Pharmaceutical & Biotech

Health Technology Platforms

Diagnostics & Laboratory

Hospital & Health Systems

Digital Health &
AI Platforms

  • 17+ Years in regulated healthcare

  • $300M+ multi-product commercial impact (cumulative)

  • 7,000+ accounts activated across Canada

  • Launch execution across pharma, biotech, diagnostics, medtech, and AI health

North America Commercialization

  • Strategic Growth AI converts Health Canada and FDA authorization into funded adoption across federal, provincial/state, and institutional layers

  • We provide embedded launch assistance for companies entering or scaling in North America

Why Strategic Growth AI

  • Not a distributor. Not a CRO. Not reimbursement-only. Not short-term advisory

  • We lead and integrate execution across pricing, HTA, negotiation, provincial listing, institutional adoption, field enablement, and governance

Healthcare innovation stalls after approval because commercialization requires alignment across multiple systems.

• regulatory approval
• reimbursement
• institutional procurement
• provider adoption
• operational integration

Image 6.png

Market Access & Reimbursement

  • Federal price compliance (PMPRB)

  • HTA strategy (CDA / INESSS)

  • Pan-Canadian negotiation positioning (pCPA)

  • Provincial listing sequencing​

Field Enablement & Specialty Channels

  • Territory cadence

  • Pharmacy & Specialty pharmacy alignment

  • PSP integration

  • Post-coverage uptake strategy

Hospital & Institutional Navigation

  • Cancer centres

  • Health authorities

  • P&T committees

  • Pathway integration

Patient Support Programs

  • In Canada, PSP must align with coverage and institutional sequencing to enable sustainable access

  • Specialty pharmacy and PSP partner coordination

  • Integration with institutional pathways and field execution

  • Alignment across payers, providers, and service partners

Launch execution must remain audit-defensible in regulated environments.

  • Separation of medical and commercial decision flows

  • Scenario planning and risk mapping

  • Compliance-aligned field guidance

  • Audit-ready documentation and change control

  • Execution tracking against defined milestones

Gemini_Generated_Image_9rqto09rqto09rqt_

Specialty Pharma Launch

Built the Canadian affiliate, aligning regulatory, market access, PSP, and field execution to achieve funded adoption and national scale.

Health Platform Launch

Rebuilt the Canadian GTM strategy, secured specialist adoption, and aligned institutions to drive scalable growth and acquisition readiness.

Diagnostic Lab Launch

Executed GTM strategy, institutional contracting, and field deployment to achieve rapid penetration across thousands of accounts.​​

Approval is the start. Coverage, institutions, and field execution determine adoption.

Schedule a Canadian Commercial Review

bottom of page